Exenatide Reduces Liver Fat in Type 2 Diabetes With Obesity

This article originally appeared here.
Share this content:
Exenatide Reduces Liver Fat in Type 2 Diabetes With Obesity
Exenatide Reduces Liver Fat in Type 2 Diabetes With Obesity

MONDAY, May 2, 2016 (HealthDay News) -- For patients with obesity and type 2 diabetes, exenatide reduces epicardial adipose tissue (EAT) and liver fat content, according to a study published online April 23 in Diabetes, Obesity and Metabolism.

Anne Dutour, M.D., Ph.D., from Inserm U1062 in Marseille, France, and colleagues randomized 44 obese patients with type 2 diabetes to receive 26 weeks of exenatide or reference treatment according to French guidelines. Forty-five minutes after a standardized meal, EAT, myocardial (MTGC), hepatic (HTGC), and pancreatic triglyceride (PTGC) content were assessed with 3-Tesla magnetic resonance imaging and 1H-magnetic resonance spectroscopy.

The researchers found that there were similar improvements in hemoglobin A1c with exenatide and reference treatment (P = 0.29). Significant weight loss was seen for exenatide only (P = 0.001 for the difference between groups). Significant reductions were seen in EAT and HTGC with exenatide versus the reference-treated group (P = 0.003 and P = 0.007, respectively). There were no significant differences in other ectopic fat stores, PTGC, or MTGC. Reductions in liver fat and EAT were not associated with homeostasis model assessment-insulin resistance, adiponectin, HbA1c, or fructosamin change in the exenatide group; they did correlate with weight loss (P = 0.03 and P = 0.018, respectively).

"Exenatide is an effective treatment to reduce liver fat content and epicardial fat in obese patients with type 2 diabetes, and these effects are mainly weight loss dependent," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »